The PLCO model may improve prediction of prostate cancer death at the point of screening. The Stockholm3 test may improve screening itself. A new prostate cancer-specific mortality (PCSM) model may ...
Next-generation Therapy for Residual Prostate Cancer A brighter future could be ahead with the next generation of prostate cancer therapy. Learn more. Immunotherapy, January 10, 2014 Repositioning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results